HRP20010650A2 - Controlled-release compositions of betahistine - Google Patents

Controlled-release compositions of betahistine Download PDF

Info

Publication number
HRP20010650A2
HRP20010650A2 HR20010650A HRP20010650A HRP20010650A2 HR P20010650 A2 HRP20010650 A2 HR P20010650A2 HR 20010650 A HR20010650 A HR 20010650A HR P20010650 A HRP20010650 A HR P20010650A HR P20010650 A2 HRP20010650 A2 HR P20010650A2
Authority
HR
Croatia
Prior art keywords
tablet
controlled release
fatty acid
release
betahistine
Prior art date
Application number
HR20010650A
Other languages
English (en)
Croatian (hr)
Inventor
Flavio Fabiani
Enrico Frimonti
Mauro Valenti
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Publication of HRP20010650A2 publication Critical patent/HRP20010650A2/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20010650A 1999-03-05 2000-02-28 Controlled-release compositions of betahistine HRP20010650A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
HRP20010650A2 true HRP20010650A2 (en) 2002-10-31

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010650A HRP20010650A2 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Country Status (37)

Country Link
EP (1) EP1158963B1 (de)
JP (1) JP2002538197A (de)
KR (1) KR20010102498A (de)
CN (1) CN1165295C (de)
AR (1) AR029154A1 (de)
AT (1) ATE231392T1 (de)
AU (1) AU762532B2 (de)
BG (1) BG105807A (de)
BR (1) BR0008739A (de)
CA (1) CA2364226A1 (de)
CO (1) CO5170438A1 (de)
CZ (1) CZ299510B6 (de)
DE (1) DE60001266T2 (de)
DK (1) DK1158963T3 (de)
EE (1) EE200100453A (de)
ES (1) ES2189739T3 (de)
GE (1) GEP20033078B (de)
HK (1) HK1042246B (de)
HR (1) HRP20010650A2 (de)
HU (1) HUP0200243A2 (de)
ID (1) ID30127A (de)
IL (1) IL145263A0 (de)
IT (1) IT1309591B1 (de)
MX (1) MXPA01008893A (de)
NO (1) NO319135B1 (de)
NZ (1) NZ513949A (de)
PE (1) PE20001547A1 (de)
PL (1) PL196290B1 (de)
PT (1) PT1158963E (de)
RU (1) RU2248791C2 (de)
SI (1) SI1158963T1 (de)
SK (1) SK284584B6 (de)
TR (1) TR200102566T2 (de)
UA (1) UA65652C2 (de)
WO (1) WO2000053162A1 (de)
YU (1) YU64001A (de)
ZA (1) ZA200107318B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585501A4 (de) * 2003-01-23 2007-04-25 Amorepacific Corp Zubereitungen mit verzögerter freisetzung und herstellungsverfahren dafür
DE60320965D1 (de) 2003-07-04 2008-06-26 Formenti Farmaceutici Spa Betahistinezubereitungen mit kontrollierter Freisetzung
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
WO2005101979A2 (en) 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
JP2008507508A (ja) * 2004-07-22 2008-03-13 株式會社アモーレパシフィック トピラメート徐放性製剤及びその製造方法
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
BRPI0912126A2 (pt) 2008-05-27 2015-11-03 Univ Melbourne método de tratamento de mamíferos com disfunções na trompa de eustáquio
EP2314296A1 (de) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Im Mund zerfallende Betahistin Tabletten
EP2491930A1 (de) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmazeutische Kombination von Betahistin mit Trimetazidin
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
EP3431078B1 (de) * 2017-07-20 2021-01-20 Intas Pharmaceuticals Limited Orale, feste betahistinzusammensetzungen mit nichtpulsatiler verlängerter freisetzung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (de) * 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
US6190591B1 (en) * 1996-10-28 2001-02-20 General Mills, Inc. Embedding and encapsulation of controlled release particles

Also Published As

Publication number Publication date
DE60001266D1 (de) 2003-02-27
EP1158963A1 (de) 2001-12-05
ITMI990454A1 (it) 2000-09-05
EP1158963B1 (de) 2003-01-22
CA2364226A1 (en) 2000-09-14
BR0008739A (pt) 2001-12-26
CN1165295C (zh) 2004-09-08
DE60001266T2 (de) 2003-08-28
NO20014301L (no) 2001-09-04
RU2248791C2 (ru) 2005-03-27
CO5170438A1 (es) 2002-06-27
NZ513949A (en) 2003-10-31
ZA200107318B (en) 2002-09-04
NO319135B1 (no) 2005-06-20
PT1158963E (pt) 2003-06-30
GEP20033078B (en) 2003-10-27
IL145263A0 (en) 2002-06-30
CN1342069A (zh) 2002-03-27
IT1309591B1 (it) 2002-01-24
PL196290B1 (pl) 2007-12-31
BG105807A (bg) 2002-03-29
WO2000053162A1 (en) 2000-09-14
CZ20013186A3 (cs) 2002-02-13
MXPA01008893A (es) 2002-10-23
PL350232A1 (en) 2002-11-18
JP2002538197A (ja) 2002-11-12
HUP0200243A2 (en) 2002-06-29
CZ299510B6 (cs) 2008-08-20
ID30127A (id) 2001-11-08
YU64001A (sh) 2004-05-12
SI1158963T1 (en) 2003-04-30
ES2189739T3 (es) 2003-07-16
ATE231392T1 (de) 2003-02-15
AU3283100A (en) 2000-09-28
UA65652C2 (uk) 2004-04-15
SK284584B6 (sk) 2005-07-01
NO20014301D0 (no) 2001-09-04
TR200102566T2 (tr) 2002-01-21
EE200100453A (et) 2002-12-16
HK1042246A1 (en) 2002-08-09
AR029154A1 (es) 2003-06-18
DK1158963T3 (da) 2003-04-28
HK1042246B (zh) 2005-06-03
AU762532B2 (en) 2003-06-26
SK12492001A3 (sk) 2001-12-03
PE20001547A1 (es) 2001-01-29
KR20010102498A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
EP0827397B1 (de) Dreiphasen-pharmazeutische form mit konstanter und gesteuerter freisetzung eines amorphen wirkstoffs zur einmaligen täglichen anwendung
KR100574207B1 (ko) 하나 이상의 활성 물질의 즉각적 및 장기적 방출을 위한정제
KR100712356B1 (ko) 서방성 제제 및 그의 제조방법
KR101094231B1 (ko) 서방성 고형 제제 및 그의 제조방법
EA014249B1 (ru) Формуляция леветирацетама длительного высвобождения
US6194005B1 (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
EP2298288A1 (de) Beschichtete Tablettenformulierung und Verfahren
KR20060053972A (ko) 토피라메이트 서방성 제제 및 그의 제조방법
KR20130041144A (ko) 데페라시록스의 경구투여용 제제
KR20080076440A (ko) 실로스타졸의 제어방출 제제 및 그 제조방법
CA2560812A1 (en) Coated tablet formulation and method
MXPA01008893A (es) Composiciones de betahistina de liberacion controlada.
KR20040006887A (ko) 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
WO2011120530A1 (en) Porous tablets as carriers for liquid formulations
CA2397942C (en) Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
KR101002583B1 (ko) 서방성 고형 제제의 제조방법
JPH0460090B2 (de)
US8722090B2 (en) Granulate comprising an oily substance, corresponding production method and tablet
WO2000025750A1 (en) Controlled-release formulations of metamizole
ITMI991737A1 (it) Composizioni a rilascio controllato di paracetamolo
RS20050038A (sr) Stabilizacija profila oslobađanja aktivnih supstanci iz formulacije
WO2001008664A1 (en) Acetylsalicylic acid controlled-release compositions

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20050309

Year of fee payment: 6

OBST Application withdrawn